RHJA
JAZZ icon

Rice Hall James & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rice Hall James & Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,095
Closed -$267K – 314
2021
Q4 		$267K Sell
2,095
-151
-7% -$19.8K 0.01% 294
2021
Q3 		$292K Sell
2,246
-270
-11% -$40.8K 0.01% 283
2021
Q2 		$447K Sell
2,516
-529
-17% -$91.6K 0.02% 264
2021
Q1 		$501K Sell
3,045
-550
-15% -$90.5K 0.02% 259
2020
Q4 		$593K Sell
3,595
-53,351
-94% -$7.95M 0.02% 253
2020
Q3 		$8.12M Buy
56,946
+20,993
+58% +$2.6M 0.33% 66
2020
Q2 		$3.97M Buy
35,953
+3,781
+12% +$418K 0.17% 118
2020
Q1 		$3.21M Sell
32,172
-677
-2% -$87.5K 0.18% 119
2019
Q4 		$4.9M Sell
32,849
-2,191
-6% -$298K 0.17% 120
2019
Q3 		$4.49M Sell
35,040
-800
-2% -$107K 0.16% 120
2019
Q2 		$5.11M Sell
35,840
-6,995
-16% -$940K 0.17% 127
2019
Q1 		$6.12M Buy
42,835
+1,301
+3% +$170K 0.2% 122
2018
Q4 		$5.15M Buy
41,534
+6,540
+19% +$970K 0.19% 125
2018
Q3 		$5.88M Sell
34,994
-493
-1% -$84.8K 0.21% 112
2018
Q2 		$6.11M Buy
35,487
+3,485
+11% +$570K 0.22% 115
2018
Q1 		$4.83M Buy
32,002
+535
+2% +$78.5K 0.19% 108
2017
Q4 		$4.24M Buy
31,467
+13,008
+70% +$1.8M 0.17% 113
2017
Q3 		$2.7M Buy
18,459
+3,563
+24% +$539K 0.12% 146
2017
Q2 		$2.32M Buy
+14,896
New +$2.28M 0.1% 168

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Rice Hall James & Associates's JAZZ Position: Q1 2022 in Review

Rice Hall James & Associates sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2022, closing a stake of 2,095 shares — an estimated $267K sold.

Rice Hall James & Associates first reported a position in JAZZ in Q2 2017 and held it in 19 quarters. The position peaked at $8.12M in Q3 2020. 462 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • Rice Hall James & Associates reported no remaining Jazz Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 2,095 Jazz Pharmaceuticals shares in Q1 2022, an estimated $267K.
  • Rice Hall James & Associates first reported a position in Jazz Pharmaceuticals in Q2 2017 and held it in 19 quarters.
  • Rice Hall James & Associates's Jazz Pharmaceuticals position peaked at $8.12M in Q3 2020.
  • 462 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.